Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EC grants marketing authorisation for Actelion’s Ledaga to treat MF-CTCL

pharmaceutical-technologyMarch 09, 2017

Tag: MF-CTCL , EC

PharmaSources Customer Service